Latest revenue
$2.9M
as of 2026-03-31
Latest net income
$-6.1M
as of 2026-03-31
Net margin
-206.8%
as of 2026-03-31
Price · 5Y
Market data
Price feed temporarily unavailable for ALUR.
5-year trend
What this company does
Item 1. Business. Unless the context otherwise requires, all references in this section to the “company”, “we”, “us”, or “our” refer to the business of Allurion Technologies, LLC, which was previously known as Allurion Technologies Opco, Inc. (formerly Allurion Technologies, Inc., a Delaware corporation formed in 2009), which is sometimes referred to as Legacy Allurion, and its subsidiaries prior to the consummation of the Business Combination, and to Allurion (formerly known as Allurion Technologies Holdings, Inc., a Delaware corporation formed in 2023) and its subsidiaries after giving effect to the Business Combination. Overview Our company is pioneering metabolically healthy weight loss…
AI summary unavailable — showing raw filing excerpt
Generated from ALUR's filing dated 2026-03-30
Key risks
Item 1A. Risk Factors. You should carefully consider the following risk factors in evaluating our business. Such risks could cause our actual results to differ materially from those that are expressed or implied by the forward-looking statements contained herein. Some risks relate principally to our business and the industry in which we operate. Others relate principally to the securities market and ownership of our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties of which we are unaware, or that we currently deem immaterial, also may become important factors that affect us. Any of the following risks could result in…
AI summary unavailable — showing raw filing excerpt
Generated from ALUR's filing dated 2026-03-30
Profitability
Gross margin
62.8%
6.2%Operating margin
-198.0%
26.7%Net margin
-188.8%
131.9%Return on equity
36.9%
0.6%Return on assets
-182.3%
128.8%Leverage
Debt / equity
-1.20×
18.0%Long-term debt / equity
0.00×
100.0%Debt / assets
594.4%
88.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $2.9M | -47.2% | $-6.1M | -306.1% | -206.8% |
Q4 2025 2025-12-31 | $3.6M | -35.4% | $-6.0M | +81.1% | -167.0% |
Q3 2025 2025-09-30 | $2.7M | -50.5% | $-11.9M | -593.1% | -447.1% |
Q2 2025 2025-06-30 | $3.4M | -71.3% | $-9.3M | -331.8% | -276.3% |
Q1 2025 2025-03-31 | $5.6M | -40.5% | $-1.5M | -126.9% | -26.9% |
Q4 2024 2024-12-31 | $5.6M | — | $-32.0M | — | -572.0% |
Q3 2024 2024-09-30 | $5.4M | -70.5% | $2.4M | +111.1% | 44.9% |
Q2 2024 2024-06-30 | $11.8M | -9.2% | $-2.2M | +90.2% | -18.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on ALUR — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$4.9K
Net activity
−$4.9K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2025-12-04 | Michael R Davin Director | Sale | 1,606 | $1.58 | $2.5K | |
| 2025-12-03 | Michael R Davin Director | Sale | 1,606 | $1.48 | $2.4K |
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ALUR
Institutional value
$8.2M
Total shares held
6.8M
Distinct holders
27
+7 vs prior
As of
2025-12-31
Prior: 2025-09-30
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 5.9M | $7.2M | +3.3M (+131.7%) | Added |
| 2 | Lunt Capital Management, Inc. | 166.7K | $205.0K | — | New |
| 3 | VANGUARD GROUP INC | 88.7K | $109.0K | +32.5K (+57.8%) | Added |
| 4 | Hudson Bay Capital Management LP | 59.9K | $87.1K | — | New |
| 5 | Empery Asset Management, LP | 59.9K | $73.7K | — | New |
| 6 | ARMISTICE CAPITAL, LLC | 59.9K | $73.7K | — | New |
| 7 | HEIGHTS CAPITAL MANAGEMENT, INC | 59.9K | $73.7K | — | New |
| 8 | L1 Global Manager Pty Ltd | 59.9K | $73.7K | — | New |
| 9 | Unisphere Establishment | 49.7K | $61.1K | +0 (+0.0%) | No change |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 40.3K | $49.6K | +709 (+1.8%) | Added |
| 11 | UBS Group AG | 29.9K | $36.7K | -29.3K (-49.5%) | Trimmed |
| 12 | STATE STREET CORP | 26.1K | $32.1K | +11.3K (+76.2%) | Added |
| 13 | BlackRock, Inc. | 18.9K | $23.2K | +0 (+0.0%) | No change |
| 14 | NORTHERN TRUST CORP | 14.8K | $18.2K | — | New |
| 15 | XTX Topco Ltd | 12.6K | $15.5K | +351 (+2.9%) | Added |
| 16 | LRI Investments, LLC | 5.0K | $6.2K | +0 (+0.0%) | No change |
| 17 | TORONTO DOMINION BANK | 162.0K | $3.2K | — | New |
| 18 | OSAIC HOLDINGS, INC. | 504 | $619 | -286 (-36.2%) | Trimmed |
| 19 | GROUP ONE TRADING LLC | 199 | $245 | +0 (+0.0%) | No change |
| 20 | Limestone Investment Advisors LP | 10.9K | $168 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ALUR's latest filing finishes processing.